Diroximel

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Appendicitis and multiple sclerosis disease-modifying therapies: a disproportionality analysis of the FDA adverse event reporting system.

Appendicitis and multiple sclerosis disease-modifying therapies: a disproportionality analysis of the FDA adverse event reporting system.

Journal: Multiple sclerosis and related disorders

Published: December 12, 2025

Comparative Effectiveness and Risk of Severe Infection in Adult Patients With MS Treated With Diroximel Fumarate Versus Anti-CD20 Monoclonal Antibodies: A Real-World Claims Analysis.

Comparative Effectiveness and Risk of Severe Infection in Adult Patients With MS Treated With Diroximel Fumarate Versus Anti-CD20 Monoclonal Antibodies: A Real-World Claims Analysis.

Journal: Advances in therapy

Published: October 23, 2025

Diroximel Fumarate-Loaded Solid Lipid Nanoparticles (DRF-SLNs) as Potential Carriers for the Treatment of Multiple Sclerosis: Preformulation Study.

Diroximel Fumarate-Loaded Solid Lipid Nanoparticles (DRF-SLNs) as Potential Carriers for the Treatment of Multiple Sclerosis: Preformulation Study.

Journal: International journal of molecular sciences

Published: October 16, 2025

Patient and healthcare provider experience of diroximel fumarate: considerations for selecting disease-modifying therapy.

Patient and healthcare provider experience of diroximel fumarate: considerations for selecting disease-modifying therapy.

Journal: Neurodegenerative disease management

Published: October 07, 2025

Matching-adjusted indirect comparisons of diroximel fumarate, ocrelizumab and interferon beta-1a for relapsing multiple sclerosis.

Matching-adjusted indirect comparisons of diroximel fumarate, ocrelizumab and interferon beta-1a for relapsing multiple sclerosis.

Journal: Journal of comparative effectiveness research

Published: September 12, 2025

Effect of diroximel fumarate on gut dysbiosis and autoimmunity in the central nervous system.

Effect of diroximel fumarate on gut dysbiosis and autoimmunity in the central nervous system.

Journal: International immunopharmacology

Published: August 22, 2025

Fumarate-based drugs protect against neuroinflammation via upregulation of anti-ferroptotic pathways.

Fumarate-based drugs protect against neuroinflammation via upregulation of anti-ferroptotic pathways.

Journal: Journal of neuroinflammation

Published: July 18, 2025

Retrospective review of lymphocyte changes when switching between fumarates in patients with multiple sclerosis.

Retrospective review of lymphocyte changes when switching between fumarates in patients with multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: April 22, 2025

Retrospective review of lymphocyte changes when switching between fumarates in patients with multiple sclerosis.

Retrospective review of lymphocyte changes when switching between fumarates in patients with multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: April 22, 2025

Herpes zoster infection in a patient with relapsing-remitting multiple sclerosis treated with diroximel fumarate.

Herpes zoster infection in a patient with relapsing-remitting multiple sclerosis treated with diroximel fumarate.

Journal: BMJ case reports

Published: April 03, 2025

Analysis of diroximel fumarate data for patients with relapsing forms of multiple sclerosis using related adverse events from the FDA adverse reporting system.

Analysis of diroximel fumarate data for patients with relapsing forms of multiple sclerosis using related adverse events from the FDA adverse reporting system.

Journal: Expert opinion on drug safety

Published: April 02, 2025

Transition from anti-CD20 therapies to fumarates as a treatment strategy: A multicenter, retrospective observational experience.

Transition from anti-CD20 therapies to fumarates as a treatment strategy: A multicenter, retrospective observational experience.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: April 01, 2025

Showing 1-12 of 77

Last Updated: 04/28/2026